IBT B — Infant Bacterial Therapeutics AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for Infant Bacterial Therapeutics AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	387	336	329	223	144
Net Total Accounts Receivable
Net Total Receivables	1.2	1.78	6.74	4.77	2.79
Prepaid Expenses
Total Other Current Assets
Total Current Assets	397	339	342	231	154
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	408	350	351	240	162
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	13.2	17.9	46.2	69.3	56.4
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	13.2	17.9	46.2	69.3	56.4
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	395	332	305	170	105
Total Liabilities & Shareholders' Equity	408	350	351	240	162
Total Common Shares Outstanding